(VIANEWS) – Arbor Realty Trust (ABR), Farmers National Banc Corp. (FMNB), eXp World Holdings (EXPI) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Arbor Realty Trust (ABR)

41.4% sales growth and 15.63% return on equity

Arbor Realty Trust, Inc. is an investor in structured finance assets. It invests in multifamily, single family rental, commercial real estate, and other markets. Structured Business is one segment of the company. Agency Business is another. The company invests mainly in real-estate-related mezzanine and bridge loans. This includes junior participation interests in first mortgages and preferred equity. It also holds real-estate-related notes, mortgage-related securities, and real-estate-related notes. It offers short-term financing to borrowers who need it to purchase property. It also underwrites and originates multifamily mortgage loans. For federal income tax purposes, the company is a real property investment trust. If it pays at least 90% of its income to stockholders, the company would generally not be subject to federal corporate income tax. Uniondale is the company’s headquarters.

Earnings Per Share

As for profitability, Arbor Realty Trust has a trailing twelve months EPS of $1.41.

PE Ratio

Arbor Realty Trust has a trailing twelve months price to earnings ratio of 8.61. Meaning,
the purchaser of the share is investing $8.61 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.63%.

Yearly Top and Bottom Value

Arbor Realty Trust’s stock is valued at $12.12 at 06:23 EST, way below its 52-week high of $20.74 and above its 52-week low of $12.01.

Dividend Yield

As stated by Morningstar, Inc., the next dividend payment is on May 18, 2022, the estimated forward annual dividend rate is 1.52 and the estimated forward annual dividend yield is 9.15%.

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is a negative 31.4% and a negative 19.6%, respectively.

Sales Growth

Arbor Realty Trust’s sales growth is 46.2% for the ongoing quarter and 41.4% for the next.

2. Farmers National Banc Corp. (FMNB)

30.8% sales growth and 15.55% return on equity

Farmers National Banc Corp. is a financial holding firm that operates in the financial, trust, retirement consulting and insurance industries. The company offers retail and commercial banking services including checking, saving, and time deposits; mortgage, installment and commercial loans; home equity line of credit; night depository; safe deposit box; money order; bank check; automated teller machine; Internet banking; travel card; E bond transaction; MasterCard and Visa credit cards; brokerage; and many other services. It also offers personal and corporate trust services, including trust administration and estate settlement; employee benefit plans; and property and casualty products and services. The company operates in 47 of the northeastern Ohio regions and in one in southwest Pennsylvania. It was established in Canfield Ohio in 1887.

Earnings Per Share

As for profitability, Farmers National Banc Corp. has a trailing twelve months EPS of $1.65.

PE Ratio

Farmers National Banc Corp. has a trailing twelve months price to earnings ratio of 8.45. Meaning,
the purchaser of the share is investing $8.45 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.55%.

Yearly Top and Bottom Value

Farmers National Banc Corp.’s stock is valued at $13.95 at 06:23 EST, way under its 52-week high of $20.00 and above its 52-week low of $13.68.

Revenue Growth

Year-on-year quarterly revenue growth grew by 12.9%, now sitting on 151.86M for the twelve trailing months.

Dividend Yield

According to Morningstar, Inc., the next dividend payment is on Sep 7, 2022, the estimated forward annual dividend rate is 0.64 and the estimated forward annual dividend yield is 4.59%.

3. eXp World Holdings (EXPI)

29% sales growth and 43.78% return on equity

eXp World Holdings, Inc. offers cloud-based brokerage services to residential homebuyers and homeowners. It allows buyers to find real-time listings of properties and sellers to sell their property through the various platforms. Buyers and sellers have access to an extensive network of professional, consumer-centric agents and brokers. The company is involved in the creation of 3D virtual environments for education and work. It focuses on technology that allows agents to create websites and portals for consumers. The company also publishes SUCCESS magazine and SUCCESS.com portal. It hosts podcasts, digital courses, newsletters, and associated social media accounts. It also provides training and marketing services for its agents and brokers through proprietary technology-enabled services as well as support and technology services that are contracted to third parties. It operates internationally in countries such as the United States of America, Canada, Australia, South Africa and Portugal. The former name of the company was eXp Realty International Corporation. In May 2016, eXp World Holdings, Inc. became eXp World Holdings, Inc.. It was incorporated in 2008.

Earnings Per Share

As for profitability, eXp World Holdings has a trailing twelve months EPS of $0.21.

PE Ratio

eXp World Holdings has a trailing twelve months price to earnings ratio of 50.05. Meaning,
the purchaser of the share is investing $50.05 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 43.78%.

Volume

Today’s last reported volume for eXp World Holdings is 657374 which is 36.26% below its average volume of 1031410.

Moving Average

eXp World Holdings’s value is way under its 50-day moving average of $14.28 and way under its 200-day moving average of $19.86.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter is a negative 20.8% and positive 26.7% for the next.

Dividend Yield

As maintained by Morningstar, Inc., the next dividend payment is on May 12, 2022, the estimated forward annual dividend rate is 0.16 and the estimated forward annual dividend yield is 1.1%.

4. Genmab (GMAB)

24.4% sales growth and 11.1% return on equity

Genmab A/S is a Danish company that develops and markets antibody therapies for cancer treatment. DARZALEX is a monoclonal human antibody that can be used to treat multiple myeloma. Teprotumumab is for treatment of thyroid disease. Ofatumurnab (a human monoclonal anti-body for chronic lymphocyticleukemia (CLL), multiple sclerosis) and Amivantamab (for advanced, metastatic, or esophageal, cancers and NSCLC) are also available. Daratumumab is used to treat MM and non-MM blood tumors and AL Amyloidosis. The company also produces products. Phase 2 includes Teclistamab to treat vaso-occlusive crisis; Camidanlumab tesirine for treatment of hodgkin lymphoma; JNJ-64407564 for treating MM; and PRV-015 to treat celiac disorder. It also has 20 preclinical trials. Seagen Inc. has granted the company a collaboration and commercial license to develop tisotumab. The company also has a partnership agreement with CureVac AG to research and develop differentiated mRNA-based antibodies products. AbbVie is responsible for developing epcoritamab. There are collaborations with BioNTech, Janssen, Novo Nordisk A/S, Bolt Biotherapeutics, Inc. Genmab A/S was established in 1999. Its headquarters are in Copenhagen, Denmark.

Earnings Per Share

As for profitability, Genmab has a trailing twelve months EPS of $0.66.

PE Ratio

Genmab has a trailing twelve months price to earnings ratio of 49.45. Meaning,
the purchaser of the share is investing $49.45 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.1%.

Yearly Top and Bottom Value

Genmab’s stock is valued at $32.69 at 06:25 EST, way below its 52-week high of $47.28 and way above its 52-week low of $26.19.

Volume

Today’s last reported volume for Genmab is 343806 which is 40.8% below its average volume of 580841.

Revenue Growth

Year-on-year quarterly revenue growth grew by 34%, now sitting on 9.02B for the twelve trailing months.

5. Amphastar Pharmaceuticals (AMPH)

15.4% sales growth and 19.1% return on equity

Amphastar Pharmaceuticals, Inc., is a specialty pharmaceutical firm that develops, manufactures, market and sells intranasal, injectable, and inhalation products. It operates in France, China, the United States, and France. Two segments of the company are Finished Pharmaceutical Products (API) and Other Products (FPP). The company offers Primatene Mist (an over-the-counter epinephrine injection product to temporarily relieve mild symptoms of intermittent asthma); Enoxaparin (a low-molecular-weight heparin that prevents and treats deep vein thrombosis); Naloxone for opioid addiction; Glucagon emergency kit; Cortrosyn, a lyophilized, powder used in diagnosis of patients suffering from adrenocortical impairment. Amphadase is a bovine-sourced, injectable hyaluronidase that can absorb and disperse other drugs. Epinephrine injections are used to treat allergic reactions. Lidocaine jelly for anesthesia for urological procedures. The topical solutions for many procedures include lidocaine, lidocaine, and phytonadione. There are also emergency syringe products available for hospital use. Morphine injections for patient-controlled analgesia pump; and lorazepam for medical procedure and for injections. It also offers Procainamide to relieve documented arrhythmias, neostigmine, a methylsulfate injection, to treat myasthenia Gravis, and reverse the effects muscle relaxants, and medroxyprogesterone topical solution for various procedures. The company serves healthcare facilities, alternative care sites, clinics and doctor’s offices. Rancho Cucamonga is the headquarters of this company, which was established in 1996.

Earnings Per Share

As for profitability, Amphastar Pharmaceuticals has a trailing twelve months EPS of $0.03.

PE Ratio

Amphastar Pharmaceuticals has a trailing twelve months price to earnings ratio of 967.67. Meaning,
the purchaser of the share is investing $967.67 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.1%.

Yearly Top and Bottom Value

Amphastar Pharmaceuticals’s stock is valued at $29.03 at 06:26 EST, way below its 52-week high of $44.46 and way higher than its 52-week low of $17.56.

Growth Estimates Quarters

The company’s growth estimates for the current quarter is 71.4% and a drop 10.9% for the next.

6. Bankwell Financial Group (BWFG)

14.3% sales growth and 16.77% return on equity

Bankwell Financial Group, Inc. is the bank holding firm for Bankwell Bank. It offers a variety of banking services and products to Connecticut’s commercial and residential customers. Deposit products offered by the bank include money market, checking and savings accounts. They also offer time, demand and certificates of deposit. It also offers commercial loans products such as owner-occupied real estate loans, investment loans in commercial real property, financing for equipment, lines of credit for small and medium-sized companies, real estate construction loans, and loans to consumers. These include loans that are secured by certificates or savings, automobiles and unsecured loans. The company has branch offices located in New Canaan and Stamford. Norwalk. Fairfield. Darien. Westport. Wilton. And Hamden. In September 2013, the company, formerly called BNC Financial Group, Inc., changed its name and became Bankwell Financial Group, Inc. Bankwell Financial Group, Inc., was established in 2002. It is located in New Canaan, Connecticut.

Earnings Per Share

As for profitability, Bankwell Financial Group has a trailing twelve months EPS of $4.44.

PE Ratio

Bankwell Financial Group has a trailing twelve months price to earnings ratio of 7.02. Meaning,
the purchaser of the share is investing $7.02 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.77%.

Moving Average

Bankwell Financial Group’s worth is under its 50-day moving average of $32.16 and under its 200-day moving average of $33.13.

Volume

Today’s last reported volume for Bankwell Financial Group is 16381 which is 61.15% below its average volume of 42166.

Sales Growth

Bankwell Financial Group’s sales growth is 23.2% for the ongoing quarter and 14.3% for the next.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is 18.4% and 3%, respectively.

7. BorgWarner (BWA)

12.9% sales growth and 10.23% return on equity

BorgWarner Inc. offers solutions worldwide for hybrid and combustion vehicles. BorgWarner Inc.’s Engine segment includes turbochargers and turbocharger actuators. It also offers eBoosters and timing system products. These include timing chains, variable timing, crankshaft and shaft sprockets tensioners guides and snubbers as well as front-wheel-drive transmission chains and four-wheel-drive chains. Emission systems include electric air pumps and exhaust gases recirculation modules (EGR), coolers and valves; glow plugs; instant starting systems; thermal system products that consist of viscous fan drive, polymer fans and coolant pumps; cabin heaters; battery heaters; and gasoline ignition technology. Its Drivetrain segment provides friction and mechanical products, including friction and separator plate, dual clutch and friction clutch module, friction and separater plates, transmission bands and torque converter, as well as torsional vibration dampers. The company also offers electro-hydraulic solenoids and transmission solenoid module, as well as dual clutch control modules. It also sells rear-wheel-drive/all-wheel-drive (AWD), transfer case systems and front-wheel-AWD coupling system systems. It sells products to light vehicle manufacturers, including passenger cars, light-duty vehicles, vans and trucks as well as commercial vehicles (including medium-duty and heavy duty trucks and buses), as well as to aftermarket suppliers for light commercial and off-highway vehicles. BorgWarner Automotive, Inc. is the former name of the company. It was established in 1987 in Auburn Hills, Michigan.

Earnings Per Share

As for profitability, BorgWarner has a trailing twelve months EPS of $2.68.

PE Ratio

BorgWarner has a trailing twelve months price to earnings ratio of 12.55. Meaning,
the purchaser of the share is investing $12.55 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.23%.

Moving Average

BorgWarner’s worth is way under its 50-day moving average of $37.52 and way under its 200-day moving average of $39.32.

Yearly Top and Bottom Value

BorgWarner’s stock is valued at $33.64 at 06:27 EST, way below its 52-week high of $50.09 and above its 52-week low of $32.28.

8. Restaurant Brands International (QSR)

9.2% sales growth and 31.44% return on equity

Restaurant Brands International Inc. is a fast-food restaurant chain in Canada. There are four main segments to the company: Tim Hortons, Burger King (BK), Popeyes Louisiana Kitchen(PLK), Firehouse Subs and Firehouse Subs. It owns the TH donut/coffee/tea restaurant chain and franchises it. They offer blend coffee, tea and espresso-based hot or cold specialty drinks. Fresh baked goods include donuts (Timbits), bagels, donuts, donuts, donuts, donuts, donuts, donuts, pastries, cookie dough, donuts and Timbits. BK is a chain of fast-food hamburger restaurants. It also owns and franchises BK. This restaurant offers flame-grilled hamburgers and chicken and other specialty sandwiches. FHS fast-service restaurants, which offer subs, soft drink, and other local specialties, are also owned and franchised by the company. The company owned approximately 29,000 restaurants across 100 countries as of February 15, 2022. Restaurant Brands International Inc. was established in 1954 in Toronto, Canada.

Earnings Per Share

As for profitability, Restaurant Brands International has a trailing twelve months EPS of $1.7.

PE Ratio

Restaurant Brands International has a trailing twelve months price to earnings ratio of 32.84. Meaning,
the purchaser of the share is investing $32.84 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 31.44%.

Moving Average

Restaurant Brands International’s worth is under its 50-day moving average of $56.13 and below its 200-day moving average of $55.88.

Yearly Top and Bottom Value

Restaurant Brands International’s stock is valued at $55.83 at 06:28 EST, way under its 52-week high of $65.56 and way higher than its 52-week low of $46.68.

Dividend Yield

According to Morningstar, Inc., the next dividend payment is on Jun 20, 2022, the estimated forward annual dividend rate is 2.16 and the estimated forward annual dividend yield is 4.03%.

Previous days news about Restaurant Brands International(QSR)

  • Restaurant brands international inc. to report third quarter 2022 results on November 3, 2022. According to Business Insider on Monday, 26 September, "TORONTO, Sept. 26, 2022 /PRNewswire/ – Restaurant Brands International Inc. (TSX:QSR) (NYSE: QSR) (TSX:QSP) will release its third quarter 2022 financial results on Thursday, November 3, 2022 and will host an investor conference call that morning at 8:30 a.m. "

LEAVE A REPLY

Please enter your comment!
Please enter your name here